Safeguard Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;'>SS</div>
SFE -- USA Stock  

USD 5.22  0.15  2.79%

Safeguard Scientifics Earnings Before Interest Taxes and Depreciation Amortization EBITDA are projected to decrease significantly based on the last few years of reporting. The past year's Earnings Before Interest Taxes and Depreciation Amortization EBITDA were at 3.08 Million. The current year Average Equity is expected to grow to about 211 M, whereas Earnings before Tax are forecasted to decline to (73.9 M). Today's short post will digest Safeguard Scientifics as your potential position. We will discuss the question of why shareholders should continue to be confident in Safeguard Scientifics outlook.
Published over a month ago
View all stories for Safeguard Scientifics | View All Stories
What can we learn from Safeguard Scientifics (NYSE:SFE) latest price fluctuation
Safeguard Scientifics has a beta of 0.2331. Let's try to break down what Safeguard's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Safeguard Scientifics will likely underperform. The beta indicator helps investors understand whether Safeguard Scientifics moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if Safeguard deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as Safeguard Scientifics New. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Predictive Modules for Safeguard Scientifics


How important is Safeguard Scientifics's Liquidity

Safeguard Scientifics financial leverage refers to using borrowed capital as a funding source to finance Safeguard Scientifics Inc ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Safeguard Scientifics financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Safeguard Scientifics's total debt and its cash.

How Safeguard utilizes its cash?

To perform a cash flow analysis of Safeguard Scientifics, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Safeguard Scientifics is receiving and how much cash it distributes out in a given period. The Safeguard Scientifics cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Safeguard Scientifics Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (19.97 Million)

What is driving Safeguard Scientifics Investor Appetite?

Safeguard Scientifics Inc exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Safeguard Scientifics Inc individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Safeguard Scientifics future systematic risk.

Returns Breakdown

Return on Investment(6.63)
Return on Assets46.48
Return on Equity69.78
Return Capital(0.25)
Return on Sales2.52

Safeguard Scientifics is projected to stay a bit over $6.34 in September

Market risk adjusted performance is down to 0.43. It may indicate a possible volatility dip. As of the 10th of August, Safeguard Scientifics has the Risk Adjusted Performance of 0.0496, semi deviation of 4.32, and Coefficient Of Variation of 3690.17. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Safeguard Scientifics New, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Safeguard Scientifics Inc, which can be compared to its competition. Please validate Safeguard Scientifics New information ratio, as well as the relationship between the value at risk and expected short fall to decide if Safeguard Scientifics is priced more or less accurately, providing market reflects its prevalent price of 6.22 per share. Given that Safeguard Scientifics New has jensen alpha of 0.0519, we advise you to double-check Safeguard Scientifics Inc's current market performance to make sure the company can sustain itself at a future point.

The Current Takeaway on Safeguard Scientifics Investment

Although some firms in the asset management industry are either recovering or due for a correction, Safeguard Scientifics may not be performing as strong as the other in terms of long-term growth potentials. With a less-than optimistic outlook for your 30 days horizon, it may be a good time to trade some or all of your Safeguard Scientifics holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Safeguard Scientifics.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Safeguard Scientifics Inc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com